Of the 33,913 KTRs with treated T2D in the cohort, 1009 were initiated on SGLT2i, 2149 were initiated on GLP1RA, and 13,641 were initiated on insulin (Table 1 and Table S1). The gene discussed is INS; the disease is type 2 diabetes mellitus.